1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Intranasal Drug Delivery Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Intranasal Drug Delivery Devices Market Revenue and Volume Forecast, by System
8.1.1. Metered Dose
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Multi-Dose Systems
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Unit-Dose Systems
8.1.3.1. Market Revenue and Volume Forecast
9.1. Intranasal Drug Delivery Devices Market Revenue and Volume Forecast, by Container
9.1.1. Non-Pressurized Containers
9.1.1.1. Market Revenue and Volume Forecast (Metered Dose)
9.1.2. Pressurized Containers
9.1.2.1. Market Revenue and Volume Forecast
10.1. Intranasal Drug Delivery Devices Market Revenue and Volume Forecast, by Application
10.1.1. Chronic Obstructive Pulmonary Disease (COPD)
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Rhinitis
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Cystic Fibrosis
10.1.3.1. Market Revenue and Volume Forecast
10.1.4. Nasal Congestion
10.1.4.1. Market Revenue and Volume Forecast
10.1.5. Asthma
10.1.5.1. Market Revenue and Volume Forecast
10.1.6. Others
10.1.6.1. Market Revenue and Volume Forecast
11.1. Intranasal Drug Delivery Devices Market Revenue and Volume Forecast, by End User
11.1.1. Ambulatory Surgical Centers
11.1.1.1. Market Revenue and Volume Forecast
11.1.2. Clinics
11.1.2.1. Market Revenue and Volume Forecast
11.1.3. Hospitals
11.1.3.1. Market Revenue and Volume Forecast
11.1.4. Others
11.1.4.1. Market Revenue and Volume Forecast
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by System
12.1.2. Market Revenue and Volume Forecast, by Container
12.1.3. Market Revenue and Volume Forecast, by Application
12.1.4. Market Revenue and Volume Forecast, by End User
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by System
12.1.5.2. Market Revenue and Volume Forecast, by Container
12.1.5.3. Market Revenue and Volume Forecast, by Application
12.1.5.4. Market Revenue and Volume Forecast, by End User
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by System
12.1.6.2. Market Revenue and Volume Forecast, by Container
12.1.6.3. Market Revenue and Volume Forecast, by Application
12.1.6.4. Market Revenue and Volume Forecast, by End User
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by System
12.2.2. Market Revenue and Volume Forecast, by Container
12.2.3. Market Revenue and Volume Forecast, by Application
12.2.4. Market Revenue and Volume Forecast, by End User
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by System
12.2.5.2. Market Revenue and Volume Forecast, by Container
12.2.5.3. Market Revenue and Volume Forecast, by Application
12.2.5.4. Market Revenue and Volume Forecast, by End User
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by System
12.2.6.2. Market Revenue and Volume Forecast, by Container
12.2.6.3. Market Revenue and Volume Forecast, by Application
12.2.6.4. Market Revenue and Volume Forecast, by End User
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by System
12.2.7.2. Market Revenue and Volume Forecast, by Container
12.2.7.3. Market Revenue and Volume Forecast, by Application
12.2.7.4. Market Revenue and Volume Forecast, by End User
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by System
12.2.8.2. Market Revenue and Volume Forecast, by Container
12.2.8.3. Market Revenue and Volume Forecast, by Application
12.2.8.4. Market Revenue and Volume Forecast, by End User
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by System
12.3.2. Market Revenue and Volume Forecast, by Container
12.3.3. Market Revenue and Volume Forecast, by Application
12.3.4. Market Revenue and Volume Forecast, by End User
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by System
12.3.5.2. Market Revenue and Volume Forecast, by Container
12.3.5.3. Market Revenue and Volume Forecast, by Application
12.3.5.4. Market Revenue and Volume Forecast, by End User
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by System
12.3.6.2. Market Revenue and Volume Forecast, by Container
12.3.6.3. Market Revenue and Volume Forecast, by Application
12.3.6.4. Market Revenue and Volume Forecast, by End User
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by System
12.3.7.2. Market Revenue and Volume Forecast, by Container
12.3.7.3. Market Revenue and Volume Forecast, by Application
12.3.7.4. Market Revenue and Volume Forecast, by End User
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by System
12.3.8.2. Market Revenue and Volume Forecast, by Container
12.3.8.3. Market Revenue and Volume Forecast, by Application
12.3.8.4. Market Revenue and Volume Forecast, by End User
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by System
12.4.2. Market Revenue and Volume Forecast, by Container
12.4.3. Market Revenue and Volume Forecast, by Application
12.4.4. Market Revenue and Volume Forecast, by End User
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by System
12.4.5.2. Market Revenue and Volume Forecast, by Container
12.4.5.3. Market Revenue and Volume Forecast, by Application
12.4.5.4. Market Revenue and Volume Forecast, by End User
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by System
12.4.6.2. Market Revenue and Volume Forecast, by Container
12.4.6.3. Market Revenue and Volume Forecast, by Application
12.4.6.4. Market Revenue and Volume Forecast, by End User
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by System
12.4.7.2. Market Revenue and Volume Forecast, by Container
12.4.7.3. Market Revenue and Volume Forecast, by Application
12.4.7.4. Market Revenue and Volume Forecast, by End User
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by System
12.4.8.2. Market Revenue and Volume Forecast, by Container
12.4.8.3. Market Revenue and Volume Forecast, by Application
12.4.8.4. Market Revenue and Volume Forecast, by End User
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by System
12.5.2. Market Revenue and Volume Forecast, by Container
12.5.3. Market Revenue and Volume Forecast, by Application
12.5.4. Market Revenue and Volume Forecast, by End User
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by System
12.5.5.2. Market Revenue and Volume Forecast, by Container
12.5.5.3. Market Revenue and Volume Forecast, by Application
12.5.5.4. Market Revenue and Volume Forecast, by End User
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by System
12.5.6.2. Market Revenue and Volume Forecast, by Container
12.5.6.3. Market Revenue and Volume Forecast, by Application
12.5.6.4. Market Revenue and Volume Forecast, by End User
13.1. Johnson & Johnson, Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Aptar Pharma Group
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. GlaxoSmithKline Plc
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Aegis Therapeutics LLC
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. H&T Presspart Manufacturing Ltd.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. AstraZeneca Plc
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Becton, Dickinson and Company
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Novartis AG
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Teleflex Incorporated
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Vectura Group Plc.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client